MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Vericel Corporation Cash Conversion Cycle 2011-2026 | VCEL
Annual Cash Conversion Cycle Vericel Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.2 | 48 | 66.9 | 105 | 109 | 112 | 104 | 53.9 | 83.2 | 75.4 | -7.73 | 21.4 | -215 K | -172 K | -204 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 112 | -215 K | -39.4 K |
Quarterly Cash Conversion Cycle Vericel Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102 | 96.4 | 82 | - | 32.6 | 38.8 | 53 | - | 69.1 | 86.8 | 105 | - | 70.1 | 60.6 | 127 | - | 125 | 93.1 | 100 | 69.6 | 122 | 185 | 128 | 74.5 | 101 | 117 | 100 | 68.3 | 95.2 | 113 | 106 | 71.4 | 117 | 98.3 | 172 | 94.4 | 143 | 122 | 90.6 | 64.6 | 88.1 | 73.3 | 80.4 | 50.8 | 77.4 | 169 | - | - | - | 122 | 160 | 88.8 | 411 | 456 | 456 | - | 91.2 | 91.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 456 | 32.6 | 118 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K |  USA |
 |
Amgen
AMGN
|
217 | $ 340.0 | -0.75 % | $ 183 B | USA |
 |
Amneal Pharmaceuticals
AMRX
|
117 | $ 12.32 | -0.24 % | $ 3.86 B | USA |
 |
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | USA |
 |
Arcutis Biotherapeutics
ARQT
|
158 | $ 23.27 | -1.63 % | $ 2.96 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
119 | $ 1.36 | -2.16 % | $ 362 M |  Britain |
 |
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | Britain |
 |
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | USA |
 |
Aytu BioScience
AYTU
|
174 | $ 2.57 | -3.38 % | $ 16.1 M | USA |
 |
Avid Bioservices
CDMO
|
85.5 | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
2.26 K | - | - | $ 1.41 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | USA |
 |
CTI BioPharma Corp.
CTIC
|
-216 | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-1.6 K | - | -4.36 % | $ 27 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
120 | $ 3.48 | -16.14 % | $ 8.76 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-101 | - | - | $ 2.18 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
459 | - | - | $ 2.02 B | USA |
 |
Dyadic International
DYAI
|
-26.6 | $ 0.88 | 1.66 % | $ 31.8 M | USA |
 |
Coherus BioSciences
CHRS
|
149 | $ 1.67 | - | $ 196 M | USA |